Many different types of radiation have been exploited to provide images of the structure and
function of tissues inside a living subject. Each imaging modality is characterized by differing …

18F-fluorodeoxyglucose positron emission tomography (FDG-PET) has been used for
detection, staging, and response monitoring in breast cancer patients. Although studies …

Precision medicine is evolving to include a variety of data to optimize patient care and
improve outcome. Multimodality imaging is paving the way toward this goal. PET/CT with 18 …

Abstract Development of partial ring, dedicated breast positron emission tomography (PET)
scanners is an active area of research. Due to the limited angular coverage, generation of …

Early detection of breast cancer is crucial for efficient and effective treatment. We have
developed an instrument for positron emission mammography (PEM) called PEM-I that …

Abstract 18F-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) has been
evaluated in breast cancer for the characterisation of primary tumours, lymph node staging …

The design and evaluation of the imaging system Clear-PEM for positron emission
mammography, under development by the PEM Consortium within the framework of the …

Although mammography remains a key imaging method for the early detection and
screening of breast cancer, the overall accuracy of this test remains low. Several …

Approaches to imaging the breast with nuclear medicine and/or molecular imaging methods
have been under investigation since the late 1980s when a technique called …

Functional imaging with positron emission tomography (PET) may be a promising technique
in conjunction with x‐ray mammography for breast cancer patient management …